Hutch News
Results per Page:
New Scientific Publications
Each week, Fred Hutch librarians search PubMed and Web of Science to discover new papers published by Fred Hutch authors
Week of June 13, 2021
AIDS@40: Stories of hope and heroes
The people and the science devoted to stopping HIV
College students muster for big COVID-19 vaccine study
12,000 participants sought in study to prove if vaccine can block asymptomatic transmission
5 reasons why a cancer research center has virology expertise
Pathogens can cause diseases, the immune system can fight them
Tip Sheet: Diversity in vaccine clinical trials, behind-the-scenes look at COVID-19 biostats, new cell therapy approved, plus meet ‘Megasphaera hutchinsoni’
Summaries of recent Fred Hutch research findings and other news
Community engagement in HIV trials guides equity for COVID-19 vaccine studies
New study highlights longstanding barriers to diversity in prior decade of vaccine trials, despite federal guidelines
Biostatisticians draft blueprints for COVID-19 vax trials
Hutch group applies skills honed during decades of HIV prevention trials to bring about safe and effective vaccines for a new pandemic
Scientists map structure of potent antibody against coronavirus
Computer-generated images show why immune protein neutralizes SARS-CoV-2
Dr. Anna Wald lauded by Infectious Diseases Society
Virologist will deliver prestigious John F. Enders Lecture during annual conference
Screening blood for a Zika virus vaccine
From the Koelle lab, University of Washington Department of Medicine and the Fred Hutch Vaccine and Infectious Disease Division
Antibodies from infected patients are a template for a SARS-CoV-2 vaccine
From the McGuire, Pancera, and Stamatatos labs, Vaccine and Infectious Disease Division
Obliteride brings in $2M to spur cancer, COVID-19 research
Annual Fred Hutch fundraiser goes virtual and DIY; sets records for participation, creativity and global reach
Scientists ponder human challenge trials for COVID-19 vaccines
Thousands offer to be infected with live virus to speed vaccine development
Experts share insights on coronavirus vaccines at Fred Hutch virtual event
Dr. Tom Lynch interviews former Hutch President Dr. Larry Corey and NIAID vaccine chief Dr. John Mascola
Q&A: Dr. Larry Corey at the center of COVID-19 vaccine research
Fred Hutch scientists will play key roles in 'harmonizing' clinical trials
Clues from coronavirus’ past
From the University of Washington and the McGuire lab, Vaccine and Infectious Disease Division
Hutch team hunts for coronavirus antibodies
Screening blood from survivors to find immune proteins for treatments and guide vaccine research
Opposing immunologic requirements in the female genital tract
From the Hladik lab, Vaccine and Infectious Disease Division
Promising HIV vaccine fails to show efficacy, trial halted
Based on earlier vaccine that was partly effective, researchers tried modified version
New HIV vaccine trial to launch in U.S., Latin America and Europe
‘Mosaico’ will enroll 3,800 transgender people and men who have sex with men
Modified HIV immunogens engage neutralizing antibody precursors
From the Stamatatos lab, Vaccine and Infectious Disease Division